WO2005113809A3 - Novel fibroblast growth factor and nucleic acids encoding same - Google Patents

Novel fibroblast growth factor and nucleic acids encoding same Download PDF

Info

Publication number
WO2005113809A3
WO2005113809A3 PCT/US2005/010731 US2005010731W WO2005113809A3 WO 2005113809 A3 WO2005113809 A3 WO 2005113809A3 US 2005010731 W US2005010731 W US 2005010731W WO 2005113809 A3 WO2005113809 A3 WO 2005113809A3
Authority
WO
WIPO (PCT)
Prior art keywords
growth factor
nucleic acids
fibroblast growth
acids encoding
encoding same
Prior art date
Application number
PCT/US2005/010731
Other languages
French (fr)
Other versions
WO2005113809A2 (en
Inventor
John Ii Alsobrook
Ferenc L Boldog
Michael E Jeffers
William J Larochelle
Denise M Lepley
Henri Lichenstein
Richard A Shimkets
Meijia Yang
Marie Ruiz-Martinez
Galina Chernaya
Muralidhara Padigaru
Sudhirdas Prayaga
Mei Zhong
Original Assignee
Curagen Corp
John Ii Alsobrook
Ferenc L Boldog
Michael E Jeffers
William J Larochelle
Denise M Lepley
Henri Lichenstein
Richard A Shimkets
Meijia Yang
Marie Ruiz-Martinez
Galina Chernaya
Muralidhara Padigaru
Sudhirdas Prayaga
Mei Zhong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/842,206 external-priority patent/US20050256039A1/en
Priority claimed from US10/980,659 external-priority patent/US20050208514A1/en
Priority claimed from US10/980,370 external-priority patent/US20060094651A1/en
Application filed by Curagen Corp, John Ii Alsobrook, Ferenc L Boldog, Michael E Jeffers, William J Larochelle, Denise M Lepley, Henri Lichenstein, Richard A Shimkets, Meijia Yang, Marie Ruiz-Martinez, Galina Chernaya, Muralidhara Padigaru, Sudhirdas Prayaga, Mei Zhong filed Critical Curagen Corp
Priority to JP2007540036A priority Critical patent/JP2008519032A/en
Priority to EP05851340A priority patent/EP1812460A1/en
Priority to PCT/US2005/039833 priority patent/WO2006055264A1/en
Priority to AU2005306898A priority patent/AU2005306898A1/en
Priority to CA002586213A priority patent/CA2586213A1/en
Publication of WO2005113809A2 publication Critical patent/WO2005113809A2/en
Publication of WO2005113809A3 publication Critical patent/WO2005113809A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factors [FGF]

Abstract

The present invention generally relates to nucleic acids, proteins, and antibodies. The invention relates more particularly to nucleic acid molecules, proteins, and antibodies of Fibroblast Growth Factor-20 (FGF-20), or its fragments, derivatives, variants, homologs, analogs, or a combination thereof.
PCT/US2005/010731 2004-05-10 2005-03-29 Novel fibroblast growth factor and nucleic acids encoding same WO2005113809A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2007540036A JP2008519032A (en) 2004-11-03 2005-11-03 Formulation, production method and use of FGF-20
EP05851340A EP1812460A1 (en) 2004-11-03 2005-11-03 Formulations, methods of production and uses of fgf-20
PCT/US2005/039833 WO2006055264A1 (en) 2004-11-03 2005-11-03 Formulations, methods of production and uses of fgf-20
AU2005306898A AU2005306898A1 (en) 2004-11-03 2005-11-03 Formulations, methods of production and uses of FGF-20
CA002586213A CA2586213A1 (en) 2004-11-03 2005-11-03 Formulations, methods of production and uses of fgf-20

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US10/842,206 US20050256039A1 (en) 2003-05-09 2004-05-10 Novel fibroblast growth factors and methods of use thereof
US10/842,206 2004-05-10
US10/980,659 US20050208514A1 (en) 1999-07-27 2004-11-03 Novel fibroblast growth factor and nucleic acids encoding dame
US10/980,370 US20060094651A1 (en) 2004-11-03 2004-11-03 Formulations and methods of production of FGF-20
US10/980,370 2004-11-03
US10/980,659 2004-11-03

Publications (2)

Publication Number Publication Date
WO2005113809A2 WO2005113809A2 (en) 2005-12-01
WO2005113809A3 true WO2005113809A3 (en) 2009-05-14

Family

ID=35428936

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/010731 WO2005113809A2 (en) 2004-05-10 2005-03-29 Novel fibroblast growth factor and nucleic acids encoding same

Country Status (1)

Country Link
WO (1) WO2005113809A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007595A2 (en) * 1999-07-27 2001-02-01 Curagen Corporation Novel fibroblast growth factor and nucleic acids encoding same
US20030186433A1 (en) * 1999-07-27 2003-10-02 Shimkets Richard A. Novel fibroblast growth factor and nucleic acids encoding same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007595A2 (en) * 1999-07-27 2001-02-01 Curagen Corporation Novel fibroblast growth factor and nucleic acids encoding same
US20030186433A1 (en) * 1999-07-27 2003-10-02 Shimkets Richard A. Novel fibroblast growth factor and nucleic acids encoding same

Also Published As

Publication number Publication date
WO2005113809A2 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
HK1098125A1 (en) Indane acetic acid compounds
WO2006029094A3 (en) Erythropoietin derivatives with altered immunogenicity
WO2004033659A3 (en) Novel tumor suppressor gene and compositions and methods for making and using the same
WO2008043822A3 (en) Amino acid sequences that bind to a desired molecule in a conditional manner
ATE408624T1 (en) METHOD FOR PURIFYING FSH
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
WO2006131564A3 (en) Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof
WO2007107587A3 (en) Cholesterol lowering protein hydrolysates
WO2008009437A3 (en) Sdf-i binding nucleic acids
WO2006101387A3 (en) Method for interfering with blood coagulation by modulating cross-beta structures fibril formation
WO2002072826A3 (en) Neurotrophic factors
WO2002014485A3 (en) Kallikrein gene
WO2001055178A3 (en) Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
WO2002024912A3 (en) Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
WO2005000888A3 (en) NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF
WO2009025300A1 (en) Peptide capable of binding to immunoglobulin
WO2004007664A3 (en) Nucleic acid vectors
WO2005018552A3 (en) Heparin binding proteins: sensors for heparin detection
WO2005000862A3 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
WO2006024041A3 (en) Monomeric and dimeric fluorescent protein variants and methods for making same
WO2005113809A3 (en) Novel fibroblast growth factor and nucleic acids encoding same
WO2005051995A3 (en) Novel advanced glycosylation end product-specific receptor-like protein and nucleic acids encoding same
AU2002328909A1 (en) Nucleic acid molecules encoding proteins essential for plant growth
WO2002062964A3 (en) Ap1 amine oxidase variants
WO2003022883A3 (en) Use of proteins for the production of a medicament for stimulating the innate non specific immune system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase